The Kappa Opioid Receptor: Candidate Pharmacotherapeutic Target for Multiple Sclerosis
Multiple sclerosis (MS) afflicts millions of people worldwide. While multiple therapeutics have recently been developed and approved as treatment agents, they are not 100% effective. Recent developments investigating the endogenous opioid system involvement in MS has revealed that agonists of the ka...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI AG
2023-11-01
|
| Seri Bilgileri: | Drugs and Drug Candidates |
| Konular: | |
| Online Erişim: | https://www.mdpi.com/2813-2998/2/4/44 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|